Do You Have a Zantac Claim?
For years, Zantac and its generic counterpart ranitidine were leading over-the-counter and prescription medications for heartburn, reflux, and similar gastrointestinal issues. However, in 2020, the Food and Drug Administration (FDA) pulled all of these products from the shelves due to high levels of the carcinogen NDMA contained in the medication. Many consumers were unknowingly ingesting these carcinogens for years. After taking Zantac regularly, many people have been diagnosed with various forms of cancer, which need highly intensive treatment or can be fatal. These can include: Breast cancer Bladder cancer Esophageal cancer Colon cancer Intestinal cancer Gastric cancer Liver cancer Kidney cancer Pancreatic cancer Lung cancer Stomach cancer Prostate cancer People who have a cancer diagnosis after taking ranitidine might be able to recover for all of their losses, including the…